Search results
18 paź 2022 · In this study, authors investigate the effect of remdesivir on recovery and long-COVID-19 symptoms, as well as quality of life and other symptom outcomes, in the 1-year follow-up of a...
21 lut 2023 · The evidence for the effect of remdesivir in patients hospitalised with COVID-19 who were receiving high-flow oxygen or more intensified respiratory support before receiving remdesivir is inconclusive, which could be related to the small sample size.
15 sie 2021 · The most common side effects in Remdesivir studies for COVID-19 include respiratory failure and organ dysfunction, including low albumin, low potassium, low red blood cell count, low platelet count, which helps clots, and yellow skin discoloration .
Remdesivir has shown a mixed result in patients with COVID-19 with an acceptable side effect. However, jury is still out while awaiting the results from the forthcoming trials. Keywords: Remdesivir, COVID-19, SARS-Co-V-2, Clinical outcome, Mortality. 1. Introduction.
This systematic review and meta-analysis—directly informing the living WHO guideline for COVID-19 therapeutics—provides a comprehensive overview of the evidence for drug-specific adverse effects of interest for three commonly used drugs for treatment of COVID-19.
30 lip 2020 · Recommendation 1 We suggest remdesivir rather than no remdesivir in patients with severe covid-19 Usual supportive care Remdesivir or 100 mg intravenously daily for 5-10 days No remdesivir Strong Weak Weak Strong Resource limited settings. Evidence profile. Individual considerations.
Introduction. Worldwide, over 131 million people have been diagnosed with Coronavirus Disease 2019 (COVID-19), resulting in nearly 2.9 million deaths [].As a global pandemic, it has resulted in a profound, negative impact on the healthcare system, economy and financial markets due to the public health crisis, loss of life, reduced productivity, business closures, trade disruption, and ...
